Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases - Guideline Learning Activities - Guideline Central

Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

American Society of Clinical Oncology

Publication Date: May 31, 2022

The Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases guideline, developed by the American Society of Clinical Oncology, provides evidence-based recommendations for the management of brain metastases in patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer.
13
Questions
26
Minutes Est.
260
Possible Points
Unrated
Difficulty
Objectives
  • Recognizing local therapy approaches for HER2–positive advanced breast cancer with brain metastases
  • Understanding management strategies for diffuse disease or extensive metastases in HER2–positive advanced breast cancer
  • Identifying systemic therapy options for HER2–positive advanced breast cancer with brain metastases
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.